Syon Capital LLC Acquires New Stake in Smith & Nephew plc (NYSE:SNN)

Syon Capital LLC bought a new position in Smith & Nephew plc (NYSE:SNN) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 13,062 shares of the medical equipment provider’s stock, valued at approximately $356,000.

Several other hedge funds also recently made changes to their positions in the company. Ridgewood Investments LLC raised its holdings in Smith & Nephew by 33.5% during the third quarter. Ridgewood Investments LLC now owns 49,106 shares of the medical equipment provider’s stock worth $1,216,000 after purchasing an additional 12,316 shares in the last quarter. SVB Wealth LLC raised its stake in shares of Smith & Nephew by 8.4% during the 3rd quarter. SVB Wealth LLC now owns 12,487 shares of the medical equipment provider’s stock worth $309,000 after buying an additional 970 shares in the last quarter. Intellectus Partners LLC lifted its holdings in shares of Smith & Nephew by 15.1% in the 3rd quarter. Intellectus Partners LLC now owns 10,761 shares of the medical equipment provider’s stock valued at $267,000 after buying an additional 1,413 shares during the period. Park Avenue Securities LLC boosted its stake in shares of Smith & Nephew by 14.3% in the third quarter. Park Avenue Securities LLC now owns 26,271 shares of the medical equipment provider’s stock valued at $651,000 after buying an additional 3,294 shares in the last quarter. Finally, Inspire Advisors LLC raised its position in Smith & Nephew by 7.4% in the third quarter. Inspire Advisors LLC now owns 13,286 shares of the medical equipment provider’s stock worth $329,000 after acquiring an additional 919 shares in the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 15th. Three investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Smith & Nephew Trading Up 2.4 %

Shares of NYSE:SNN opened at $24.45 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.77 and a quick ratio of 0.72. The business’s 50 day simple moving average is $25.99 and its 200-day simple moving average is $25.98. Smith & Nephew plc has a 12 month low of $21.52 and a 12 month high of $33.08.

Smith & Nephew Dividend Announcement

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Tuesday, April 2nd will be given a dividend of $0.462 per share. The ex-dividend date of this dividend is Monday, April 1st. This represents a yield of 2.8%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.